The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, a new study published by The BMJ has found, with the risk seemingly increased with increasing duration of use and dose.
Fasting less than 13 hours per night was associated with an increased risk for breast cancer recurrence in women with early-stage breast cancer, according to an article published online by JAMA Oncology.
With PSA testing, there is an increased tendency to detect prostate cancer but with time, that advantage diminishes, Gary Culliton reports in his latest Clinical Update. The need for testing in the low-risk group, is very much reduced.
New data has supported the case for some patients taking abiraterone for long periods of time, Britain’s National Institute for Health and Care Excellence (NICE) has said. NICE has issued final guidance recommending abiraterone for some prostate cancer patients.
A team of researchers from the Centre for Chromosome Biology at NUI Galway, in collaboration with the IFOM Research Institute in Milan, Italy, have discovered that a protein named USP9X contributes to the efficient duplication of the DNA in cells and may help in the battle against cancer.
A high ratio of two types of immune system cell is linked to an increased risk of disease recurrence after a diagnosis of early-stage breast cancer, finds the first study of its kind, published in the online journal ESMO Open, which could open to way for future treatment and monitoring strategies.
A new study of breast cancer screening, published online by JAMA Oncology, suggests 3D digital breast tomosynthesis (DBT) outcomes were sustainable with significant reduction in patient recall, increasing cancer cases per recalled patients and a decline in interval cancers.
An individual approach to breast cancer treatment is now preferred, Gary Culliton reports in his latest Clinical Update. The way drugs are administered and scheduled is now much more specific to the type of disease involved.
Rates of genetic testing for the BRCA1 and BRCA2 gene mutations have increased among women diagnosed with cancer aged 40 years and under, US research has found.
Head and neck cancer can have a serious and long-lasting financial and emotional impact, not just on the patients alone, but also on their carers who are often older and poorer, according to a new research by the National Cancer Registry (NCRI), published in the Journal of Psycho-Oncology.